HEGG, R.; MATTAR, A.; MATOS-NETO, J. N. de; PEDRINI, J. L.; ALEIXO, S. B.; ROCHA, R. O.; CRAMER-JUNIOR, R. P.; VAN-EYLL-ROCHA, S. A phase III, randomized, non-inferiority study comparing the efficacy and safety of biosimilar filgrastim versus originator filgrastim for chemotherapy-induced neutropenia in breast cancer patients . Clinics, [S. l.], v. 71, n. 10, p. 586-592, 2016. DOI: 10.6061/clinics/2016(10)06. Disponível em: https://www.revistas.usp.br/clinics/article/view/122233. Acesso em: 2 dec. 2023.